Showcases Stock ranks Forex

Pfizer Inc (PFE)
37.23  0.7 (1.92%) 11-27 13:02
Open: 36.78 Pre. Close: 36.53
High: 37.26 Low: 36.75
Volume: 25,080,500 Market Cap: 206,939M
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 36.645 - 36.826 36.826 - 36.972
Low: 35.733 - 35.982 35.982 - 36.185
Close: 36.182 - 36.558 36.558 - 36.864
Stock Technical Analysis
Target: Six months: 46.53
One year: 54.35
Support: Support1: 35.51
Support2: 32.83
Resistance: Resistance1: 39.84
Resistance2: 46.53
Pivot: 36.32
Moving Averages: MA(5): 36.72
MA(20): 35.85
MA(100): 35.34
MA(250): 34.74
MACD: MACD(12,26): 0.46
Signal(12,26,9): 0.36
%K %D: %K(14,3): 45.48
%D(3): 43.55
RSI: RSI(14): 60.05
52-Week: High: 39.83871
Low: 26.451612
Change(%): 2.5
Average Vol(K): 3-Month: 3369095
10-Days: 4634631
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

PFE has closed below upper band by 16.0%. Bollinger Bands are 7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 27 Nov 2020
Pfizer Inc. (PFE) Rises 1.92% for November 27 -

Fri, 27 Nov 2020
Reason’s why Pfizer Inc. (PFE) is an asset to your trade with current Target Price of $41.78 - The InvestChronicle

Fri, 27 Nov 2020
Pfizer Inc (PFE) Down 0.19%; Pin Bar Pattern Appearing on Chart - CFD Trading

Wed, 25 Nov 2020
Should Value Investors Pick Pfizer (PFE) Stock Right Now? - Yahoo Finance

Wed, 25 Nov 2020
Pfizer Inc (PFE) Up 0.22%; Price Base in Formation Over Past 30 Days - CFD Trading

Wed, 25 Nov 2020
PFE Stock Price and Quote: Pfizer Inc trades flat as biotech rivals join COVID-19 vaccine race - FXStreet

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 5560.00
Shares Float (M) 5550.00
% Held by Insiders 0.05
% Held by Institutions 70.75
Shares Short (K) 45930
Shares Short Prior Month (K) 45160
Stock Financials
EPS 1.540
Book Value (p.s.) 11.740
Profit Margin 17.85
Operating Margin 29.24
Return on Assets (ttm) 5.1
Return on Equity (ttm) 13.3
Qtrly Rev. Growth -4.3
Gross Profit (p.s.) 7.507
Sales Per Share 8.750
EBITDA (p.s.) 3.475
Qtrly Earnings Growth -71.40
Operating Cash Flow (M) 12550.00
Levered Free Cash Flow (M) -655.25
Stock Valuation
PE Ratio 24.18
PEG Ratio 2.34
Price to Book value 3.17
Price to Sales 4.25
Price to Cash Flow 16.49
Stock Dividends
Dividend 1.500
Dividend Yield 0.04
Dividend Growth 1.520

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator